Transfusion Medicine
Conference Coverage
Beta-thalassemia gene therapy achieves lasting transfusion independence
“Seeing the restoration of iron metabolism, it really takes us a step closer to really thinking the term ‘cure’ might truly apply.”
Latest News
Risk-based antenatal type-and-screen blood testing safe and economical
“In a year of selective type and screen, we saw a 51% reduction in costs related to type and screen, and a 38% reduction in overall transfusion-...
From the Journals
Hemochromatosis variants may confer 10-fold higher risk of liver cancer
Men of European ancestry had a greater risk of liver cancer and death if they had HFE variants.
From the Journals
INR fails to predict bleeding in patients with cirrhosis
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international...
Conference Coverage
Study finds no link between platelet count, surgery bleed risk in cirrhosis
Logistic regression analysis showed no significant association between platelet count and major bleeding events.
Latest News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available...
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
Feature
Can convalescent plasma treat COVID-19 patients?
How COVID-19 patients can receive convalescent plasma, who is eligible to donate, and early results of treatment.
Conference Coverage
Think twice: Choosing Wisely recommendations on testing to avoid in pediatric hematology
ORLANDO – The list, which was released by ASH and the American Society of Pediatric Hematology/Oncology, includes five unnecessary tests or...
Conference Coverage
Transfusion-related lung injury is on the rise in elderly patients
SAN ANTONIO – Researchers at the Food and Drug Administration examined trends in potentially life-threatening or fatal transfusion-related adverse...
News from the FDA/CDC
FDA approves anemia treatment for transfusion-dependent beta thalassemia patients
Luspatercept-aamt (Reblozyl) is approved for adults with beta thalassemia who require regular red blood cell transfusions.